the present invention is directed to a topical ophthalmic composition for a liquid comprised of clear colloidal polar nanolipids delivered in submicron sized particles , aqueous colloidal lubricants , aqueous polymers , emulsifies , and a unique stabilizing buffer system , which undergoes a liquid - gel phase transition in the eye . said composition is designed to deliver advanced eye lubricants , protect the three layers of corneal film from dryness , and provide a unique system of dry eye treatment that addresses and treats all three layers of corneal tear film . said composition is further designed to provide a superior delivery system of various active pharmaceutical ingredients , and / or anti - infective / antibiotic / anti - fungal agents , accepted as safe and efficacious for ophthalmic use .